Cite
HARVARD Citation
Gouni-Berthold, I. et al. (2021). Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet. 9 (5), pp. 264-275. [Online].